factor

(redirected from factor VIII)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to factor VIII: Factor VIII deficiency

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
"This medicine has been stockpiled in the storage house of this domestic company," said Sattari, adding, "that comes as Factor VIII is not a medicine that could be stored for a long time."
The HAVEN program is one of the largest pivotal clinical trial programs in hemophilia A, designed to assess the efficacy and safety of Hemlibra in hemophilia A in people with and without factor VIII inhibitors.
HAVEN 1 has formed the basis of Hemlibra's approval in people with hemophilia A with factor VIII inhibitors in over 70 countries worldwide to date.
Hemlibra is approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in people with haemophilia A with factor VIII inhibitors in over 70 countries worldwide, based on the results of the pivotal HAVEN 1 and HAVEN 2 studies.
The rationale of the study was to find out the load of factor VIII inhibitors in factor VIII deficient patients so as to formulate a comprehensive and elaborative strategy for further investigations and theratment and will be implemented in all military health care setups.
In our present study also, 47 (74.6%) patients had severe factor VIII deficiency, 12 (19%) patients had moderate factor VIII deficiency and 4 (6.4%) patients had mild factor VIII deficiency; 11 (68.7%) patients had severe factor IX deficiency, 4 (25%) patients had moderate factor IX deficiency and one patient had mild factor IX deficiency.
The patient's corrected cells placed in the implanted Cell Pouch will release factor VIII on a continual basis at a rate that would be expected to significantly reduce disease-associated hemorrhaging and joint damage.
(1-3) Underlying disorders are associated with the development of a factor VIII inhibitor in about half of cases, with the most common being autoimmune disorders (12%), malignancy (7-15%), pregnancy or post-partum (10%), drug reactions (3-6%), and dermatological disorders (2-5%).
Only Robert and one other man are alive of the 16 men given the same batch of Factor VIII at Edinburgh Royal Infirmary.
The diagnosis was acquired haemophilia caused by the formation of factor VIII inhibitors in her serum.
Nevertheless, acute coronary syndrome can be provoked by the administration of recombinant factor VIII or DDAVP [3, 4].